Tatva Chintan Pharma Chem Limited logo

TATVA

NSE
Tatva Chintan Pharma Chem Limited (SMALL CAP)
Commodities>Chemicals>Chemicals & Petrochemicals>Specialty Chemicals
1,326.50
87.30 (7.04%)
High VOLATILITY
As on 10 Jul 2026

Price History

Market Cap
₹3.10K Cr
SMALL CAP
P/E Ratio
68.9
Industry
Specialty Chemicals
52-Week Range
52W Low919.75+44.2%
52W High1,610-17.6%
Current Price
1,326.50
Circuit Limits (20%)
Lower Circuit1,061.20
Upper Circuit1,591.80
Reference Price
1,326.50

Investment Checklist

Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹1519.0
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹1519.0
Composite score 81.7 (STRONG_BUY) with 90.6% confidence
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Unusual volume detected (2.8x average) — institutional activity likely

Technical Analysis

Technical Analysis

Analysis from 2026-07-10

Confidence
91%

Trend

BULLISH
BULLISH

Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

EMA20
1223.07
EMA50
1217.35
EMA200
1215.14

Price Action

UPTREND
BULLISH
Higher Highs7
Higher Lows6
Lower Highs2
Lower Lows3

Support & Resistance Levels

Resistance (Above)
1360.50
1393.90
1420.00
1489.70
1582.00
Support (Below)
1323.00
1293.30
1246.71
1208.00
1167.90

Volume Analysis

TrendINCREASING
Change+46.30%
Unusual Volume
Yes (2.81x avg)

Recent Price Gaps

Gap Down
3 days ago • 0.26%(Filled)
BEARISH

Stop Loss Levels

Fixed Risk

1% Risk1313.23
3% Risk1286.70
5% Risk1260.17
7% Risk (Custom)
1233.64

Technical Levels

1x ATR (Volatility)1274.04
2x ATR (Swing)1221.58
3x ATR (Trend)1169.12
Immediate Support1323.00

Moving Averages

EMA 9 (Short-term)1242.79
EMA 20 (Medium-term)1223.07
EMA 50 (Trend)1217.35
EMA 200 (Long-term)1215.14

Financials

Financial Analysis

MetricMar '25Jun '25Sep '25Dec '25
Revenue₹105.1 Cr₹116.9 Cr₹123.5 Cr₹131.3 Cr
Net Profit₹1 Cr₹6.7 Cr₹9.9 Cr₹15.2 Cr
EPS₹2.84₹4.24₹6.49
Operating Profit₹9.3 Cr₹18.5 Cr₹23.2 Cr₹27.2 Cr
ROE
0.77%
ROCE
1.09%
Debt/Equity
0.05
Current Ratio
2.76
OPM
20.73%
NPM
11.55%

Peer Comparison

Specialty Chemicals

Peer Comparison

Symbol
Name
Price
Change
P/E Ratio
Market Cap
Pidilite Industries Limited₹1,598.50+0.51%65.5
₹1.63L Cr
SRF Limited₹2,774.60+0.64%44.5
₹82.25K Cr
Gujarat Fluorochemicals Limited₹3,941.50+2.02%73.8
₹43.30K Cr
Navin Fluorine International Limited₹7,712.00+0.30%59.4
₹39.51K Cr
Deepak Nitrite Limited₹1,644.00+1.41%40.2
₹22.42K Cr
Aether Industries Limited₹1,500.80+1.01%89.9
₹19.91K Cr
Atul Limited₹6,236.00+0.86%26.6
₹18.36K Cr
Aarti Industries Limited₹484.10+3.45%40.5
₹17.55K Cr
BASF India Limited₹3,543.80+1.91%36.4
₹15.34K Cr
Fine Organic Industries Limited₹4,999.50+0.60%36.3
₹15.33K Cr
Tatva Chintan Pharma Chem Limited₹1,326.50+7.04%68.9
₹3.10K Cr

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All
Ex DatePurposeType
12 Sept 2025
Dividend - Re 1 Per Share
DIVIDEND
06 Sept 2024
Dividend - Rs 2 Per Share
DIVIDEND
06 Sept 2024
Annual General Meeting
AGM
08 Sept 2023
Annual General Meeting
AGM
08 Sept 2023
Dividend - Rs 2 Per Share
DIVIDEND

Announcements

Latest updates

View All
DateDescriptionLink
11 Jul 2026
Analysts/Institutional Investor Meet/Con. Call Updates
06 Jul 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
24 Jun 2026
Disclosure under SEBI Takeover Regulations
23 Jun 2026
Trading Window
12 Jun 2026
Analysts/Institutional Investor Meet/Con. Call Updates

Board Meetings

Upcoming and past meetings

View All
DatePurposeLinks
16 May 2026
Financial Results/Dividend
16 May 2026
Board Meeting Intimation
21 Jan 2026
Board Meeting Intimation
21 Jan 2026
Financial Results
31 Oct 2025
Board Meeting Intimation

Corporate Events

Upcoming results & meetings

View All
DatePurposeType
17 Jul 2026
Financial Results
RESULTS

Shareholding Pattern

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for TATVA

View All
NEWS
negative
Business Standard - Markets 50d ago

Link Pharma Chem reports standalone net loss of Rs 0.41 crore in the March 2026 quarter

Sales rise 2.17% to Rs 6.59 crore

DLINKINDIATATVAChemicalsInformation Technology
NEWS
positive
Business Standard - Markets 55d ago

Tatva Chintan Pharma Chem standalone net profit rises 720.00% in the March 2026 quarter

Sales rise 23.24% to Rs 132.67 crore

TATVAChemicals

Frequently Asked Questions